Clinical Research Directory
Browse clinical research sites, groups, and studies.
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Sponsor: Massachusetts Eye and Ear Infirmary
Summary
This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2020-09-16
Completion Date
2027-04-30
Last Updated
2025-09-29
Healthy Volunteers
No
Conditions
Interventions
N-acetyl cysteine (NAC) 10% solution
N-acetyl cysteine is a sterile, unpreserved eye drop containing 10% (100 mg/mL) of acetylcysteine.
N-acetyl cysteine (NAC) 20% solution
N-acetyl cysteine is a sterile, unpreserved eye drop containing 20% (200 mg/mL) of acetylcysteine.
Visine Dry Eye Relief eye drops
Visine Tears Dry Eye Relief artificial tears ophthalmic solution
Locations (1)
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States